[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 59, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 56, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 58, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lynda  Harris", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 35, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 73, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.95, "open": 12.4755, "dayLow": 12.2, "dayHigh": 13.14, "regularMarketPreviousClose": 10.95, "regularMarketOpen": 12.4755, "regularMarketDayLow": 12.2, "regularMarketDayHigh": 13.14, "payoutRatio": 0.0, "beta": 0.739, "forwardPE": -9.674074, "volume": 5995596, "regularMarketVolume": 5995596, "averageVolume": 1956782, "averageVolume10days": 1870880, "averageDailyVolume10Day": 1870880, "bid": 7.53, "ask": 12.83, "bidSize": 2, "askSize": 2, "marketCap": 1290962816, "fiftyTwoWeekLow": 6.66, "fiftyTwoWeekHigh": 18.9, "allTimeHigh": 63.41, "allTimeLow": 2.55, "priceToSalesTrailing12Months": 9.042129, "fiftyDayAverage": 9.7153, "twoHundredDayAverage": 12.77265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2463521792, "profitMargins": -0.56061, "floatShares": 105406228, "sharesOutstanding": 98848611, "sharesShort": 21588277, "sharesShortPriorMonth": 20140227, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.2184, "heldPercentInsiders": 0.16826001, "heldPercentInstitutions": 0.86583, "shortRatio": 10.04, "shortPercentOfFloat": 0.35580003, "impliedSharesOutstanding": 98848611, "bookValue": 1.494, "priceToBook": 8.741633, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -80040000, "trailingEps": -0.81, "forwardEps": -1.35, "enterpriseToRevenue": 17.255, "enterpriseToEbitda": -27.431, "52WeekChange": 0.15985787, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 13.06, "targetHighPrice": 39.0, "targetLowPrice": 12.0, "targetMeanPrice": 28.83333, "targetMedianPrice": 31.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 288208992, "totalCashPerShare": 1.458, "ebitda": -89807000, "totalDebt": 169804992, "quickRatio": 6.406, "currentRatio": 6.66, "totalRevenue": 142772000, "debtToEquity": 115.001, "revenuePerShare": 1.454, "returnOnAssets": -0.19221, "returnOnEquity": -0.45916, "grossProfits": 114873000, "freeCashflow": -56190248, "operatingCashflow": -85377000, "revenueGrowth": 14.716, "grossMargins": 0.80459, "ebitdaMargins": -0.62902, "operatingMargins": -1.6366299, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1768006796, "regularMarketTime": 1767992401, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": -0.46708134, "postMarketPrice": 12.999, "postMarketChange": -0.061000824, "regularMarketChange": 2.11, "regularMarketDayRange": "12.2 - 13.14", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1956782, "fiftyTwoWeekLowChange": 6.4000006, "fiftyTwoWeekLowChangePercent": 0.96096104, "fiftyTwoWeekRange": "6.66 - 18.9", "fiftyTwoWeekHighChange": -5.839999, "fiftyTwoWeekHighChangePercent": -0.30899468, "fiftyTwoWeekChangePercent": 15.985786, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "earningsCallTimestampStart": 1762781400, "earningsCallTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.81, "epsForward": -1.35, "epsCurrentYear": -1.7875, "twoHundredDayAverageChangePercent": 0.022497341, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 19.2694, "regularMarketPrice": 13.06, "priceEpsCurrentYear": -7.306294, "fiftyDayAverageChange": 3.3447008, "fiftyDayAverageChangePercent": 0.3442715, "twoHundredDayAverageChange": 0.28735065, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2026-01-09", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]